JPMorgan Starts Diplomat Pharmacy (DPLO) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Oil slips but stays near six-month highs on Saudi attacks
- Brazilās Lula wins historic fourth term, Flavio Bolsonaro refuses to concede
- Borr Drilling rig sinks off Gabon, one person dead and four missing
- Britain will not join Canada-led defence bank initiativeĀ
- Serbia's Vucic concedes defeat to student led movement in parliamentary election
- Stocks, bonds edge up ahead of 'formidable' week for risk
Credit Suisse Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 9:25 AM ESTCredit Suisse initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $29.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreWells Fargo Starts Diplomat Pharmacy (DPLO) at Market Perform
November 19, 2014 8:50 AM ESTWells Fargo initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with a Market Perform rating and a price target of $24-$26.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreWilliam Blair Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:35 AM ESTWilliam Blair initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... MoreLeerink Swann Starts Diplomat Pharmacy (DPLO) at Outperform
November 19, 2014 7:28 AM ESTLeerink Swann initiated coverage on Diplomat Pharmacy (NYSE: DPLO) with an Outperform rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Diplomat Pharmacy click here. For more ratings news on Diplomat Pharmacy click here.
Shares of Diplomat Pharmacy closed at $24.01 yesterday.
... More


